Discontinued — last reported Q2 '23
Business Segments · Malpractice accrual
Pharma Solutions — Malpractice accrual
International Flavors & Fragrances Pharma Solutions — Malpractice accrual decreased by 36.8% to $12M in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 63.6%, from $33M to $12M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ2 2023Aug 9, 2023
How to read this metric
An increase suggests higher perceived legal risk or pending litigation, while a decrease indicates a reduction in estimated liability or successful resolution of claims.
Detailed definition
Represents the total financial liability reserved on the balance sheet for potential legal claims or professional liabil...
Peer comparison
Commonly reported by pharmaceutical and specialty chemical companies as legal reserves or litigation accruals.
Metric ID:
iff_segment_pharma_solutions_malpractice_accrualHistorical Data
7 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|
| Value | $40M | $30M | $33M | $34M | $34M | $19M | $12M |
| QoQ Change | — | -25.0% | +10.0% | +3.0% | +0.0% | -44.1% | -36.8% |
| YoY Change | — | — | — | — | -15.0% | -36.7% | -63.6% |
Range$12M – $40M
CAGR-55.2%
Avg YoY Growth-38.4%
Median YoY Growth-36.7%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's pharma solutions — malpractice accrual?
- International Flavors & Fragrances (IFF) reported pharma solutions — malpractice accrual of $12M in Q2 2023.
- How has International Flavors & Fragrances's pharma solutions — malpractice accrual changed year-over-year?
- International Flavors & Fragrances's pharma solutions — malpractice accrual decreased by 63.6% year-over-year, from $33M to $12M.
- What does pharma solutions — malpractice accrual mean?
- The total amount of money set aside to cover potential legal or professional liability claims in the pharmaceutical business.